Biogen (BIIB) Shares Shoot Up 40% after FDA Approval of Its Alzheimer’s Drug

Coinspeaker
Biogen (BIIB) Shares Shoot Up 40% after FDA Approval of Its Alzheimer’s Drug

Regardless of the heated debates on the drug’s efficacy, Biogen (BIIB) stock has taken an uptrend, with the latest gain being the 4th in a row of gains in the past week.

Biogen (BIIB) Shares Shoot Up 40% after FDA Approval of Its Alzheimer’s Drug

Coinspeaker

4 total views, 1 views today

Author: toutiao